Hugel, Inc.
A biopharmaceutical company developing and distributing medical aesthetic products.
145020 | KO
Overview
Corporate Details
- ISIN(s):
- KR7145020004
- LEI:
- Country:
- South Korea
- Address:
- 강원특별자치도 춘천시 동내면 거두단지1길 23 -, 춘천시
- Website:
- https://www.hugel-inc.com/
- Sector:
- Manufacturing
Description
Hugel, Inc. is a global biopharmaceutical company specializing in the medical aesthetics and therapeutics market. The company develops, manufactures, and distributes a portfolio of high-quality products, including its flagship botulinum toxin type A formulations, known commercially as Botulax and Letybo. Its product line also features a range of hyaluronic acid (HA) fillers and PDO threads. Recognized as a leader in its field, Hugel is focused on providing innovative, efficient, and proven solutions to medical professionals worldwide. The company is committed to advancing aesthetic medicine through continuous research and development to create effective and reliable treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-05-04 00:00 |
투자판단관련주요경영사항(보툴리눔 톡신 무통 액상제제 "HG102" 임상1상 시험 결과)
|
Korean | 12.6 KB | ||
| 2022-05-04 00:00 |
기타시장안내(최대주주의의무보유관련)(의무보유 대상 여부 확인을 위한 계약서 제출 관련)
|
Korean | 4.7 KB | ||
| 2022-05-03 00:00 |
투자판단관련주요경영사항(미국 국제무역위원회(ITC, International Trade Commission) 조사 개시 결정)
|
Korean | 6.1 KB | ||
| 2022-05-03 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 28.5 KB | ||
| 2022-05-02 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 25.2 KB | ||
| 2022-05-02 00:00 |
[기재정정]최대주주변경
|
Korean | 40.5 KB | ||
| 2022-05-02 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 13.1 KB | ||
| 2022-04-29 00:00 |
임시주주총회결과
|
Korean | 22.3 KB | ||
| 2022-04-29 00:00 |
[기재정정]최대주주변경을수반하는주식양수도계약체결
|
Korean | 32.9 KB | ||
| 2022-04-29 00:00 |
최대주주변경
|
Korean | 36.6 KB | ||
| 2022-04-29 00:00 |
기타시장안내(최대주주의의무보유관련)
|
Korean | 4.4 KB | ||
| 2022-04-29 00:00 |
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
|
Korean | 13.5 KB | ||
| 2022-04-29 00:00 |
최대주주변경을수반하는주식담보제공계약체결
|
Korean | 21.6 KB | ||
| 2022-04-20 00:00 |
투자판단관련주요경영사항(보툴렉스(Botulax, 수출명 Letybo) 50유닛의 독일 품목허가 획득)
|
Korean | 8.6 KB | ||
| 2022-04-14 00:00 |
주주총회소집결의
|
Korean | 21.4 KB |
Automate Your Workflow. Get a real-time feed of all Hugel, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Hugel, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Hugel, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
